Crystalline coating and release of bioactive agents

Patent metadata

Field	Value
Publication number	US-10137225-B2
Application number	US-201615361426-A
Country	US
Kind code	B2
Filing date	Nov 27, 2016
Priority date	May 27, 2014
Publication date	Nov 27, 2018
Grant date	Nov 27, 2018

Abstract

Articles-of-manufacturing comprising an object having a surface and at least a first layer of a first therapeutically active agent being deposited onto at least a continuous portion of the surface, wherein at least 50 weight percents of the first layer is the first therapeutically active agent in a crystalline form are disclosed. Methods utilizing such articles-of-manufacturing for treating medical conditions are also disclosed. Processes of preparing the articles-of-manufacturing by contacting a surface of the object with a solution containing the therapeutically active agent, without cooling the surface to a temperature below a temperature of the solution, are also disclosed.

First claim

What is claimed is:

1. A process of depositing at least a first layer of a first therapeutically active agent onto at least a continuous portion of a surface of an object, wherein at least 50 weight percents of said first layer is said first therapeutically active agent in a crystalline form, the process comprising:
seeding said surface of said object with crystals of said first therapeutically active agent, so as to obtain a seeded surface comprising said crystals; and
contacting said seeded surface with a solution containing said first therapeutically active agent for at least 5 minutes, so as to effect precipitation of said first therapeutically active agent onto said seeded surface in a crystalline form, thereby forming said crystalline form of said first therapeutically active agent deposited on at least said portion of said surface,
wherein said surface is not cooled to a temperature below a temperature of said solution.

2. The process of claim 1 , further comprising depositing at least one additional layer comprising a second therapeutically active agent onto said surface, wherein said second therapeutically active agent is said first therapeutically active agent in an amorphous form and/or in a different crystalline form than in said first layer, or said second therapeutically active agent is a different therapeutically active agent than said first therapeutically active agent.

3. The process of claim 1 , wherein said seeding comprises contacting said surface with a dispersion of said crystals of said first therapeutically active agent.

4. The process of claim 1 , wherein said seeded surface comprises said crystals at a density in a range of from 0.03 μg/mm 2 to 3 μg/mm 2 .

5. The process of claim 1 , wherein a concentration of said first therapeutically active agent in said solution contacted with said seeded surface is no more than 1 mg/ml.

6. The process of claim 1 , further comprising applying a top coat onto said surface having said first layer deposited thereon.

7. The process of claim 1 , wherein when said object further comprises a base layer applied onto at least a portion of said surface, and at least one nucleating agent conjugated to said base layer, the process further comprises, prior to seeding said surface, applying said base layer and said nucleating agent conjugated to said base layer onto said surface.

8. A process of depositing a first layer of a first therapeutically active agent onto at least a continuous portion of a surface of an object, wherein at least 50 weight percents of said first layer is said first therapeutically active agent in a crystalline form, the process comprising:
seeding said surface of said object with crystals of said first therapeutically active agent, so as to obtain a seeded surface comprising said crystals;
contacting said seeded surface with a solution containing said first therapeutically active agent for at least 5 minutes, so as to effect precipitation of said first therapeutically active agent onto said seeded surface in a crystalline form, thereby forming said crystalline form of said first therapeutically active agent deposited on at least said portion of said surface; and
applying a top coat comprising hyaluronic acid onto said surface having said first therapeutically active agent deposited thereon.

Assignees

• Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd

Inventors

• Domb Abraham Jacob
• Farah Shady

Classifications

• A61L2300/204

  with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines · CPC title

• A61F2250/0067

  Means for introducing or releasing pharmaceutical products into the body · CPC title

• A61L2420/08

  Coatings comprising two or more layers · CPC title

• C09D105/08

  Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title

• A61L31/16

  Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title